Becattini, Cecilia http://orcid.org/0000-0002-8343-4888
Agnelli, Giancarlo
Maggioni, Aldo Pietro
Dentali, Francesco
Fabbri, Andrea
Enea, Iolanda
Pomero, Fulvio
Ruggieri, Maria Pia
Di Lenarda, Andrea
Gulizia, Michele
Clinical trials referenced in this document:
Documents that mention this clinical trial
Acute pulmonary embolism and cancer: findings from the COPE study
https://doi.org/10.1007/s00392-023-02323-z
Contemporary Management and Clinical Course of Acute Pulmonary Embolism: The COPE Study
https://doi.org/10.1055/a-2031-3859
Contemporary clinical management of acute pulmonary embolism: the COPE study
https://doi.org/10.1007/s11739-021-02855-0
Funding for this research was provided by:
Daiichi-Sankyo
Università degli Studi di Perugia
Article History
Received: 2 July 2021
Accepted: 16 September 2021
First Online: 4 January 2022
Declarations
:
: C.B. reports personal fees from Bayer HealthCare, Bristol Myers Squibb and Daiichi Sankyo all outside the submitted study. G.A. reports personal fees from Pfizer, personal fees from Bayer Healthcare, from Daichi Sankyo, outside the submitted work. A.P.M. reports honoraria for participation in committees of studies sponsored by Bayer, Novartis and Fresenius. M.M.G., A.L., F.D., I.E., F.P., A.F., M.P.R. have nothing to disclose.
: Cecilia Becattini, Michele Gulizia, Giancarlo Agnelli, Aldo P Maggioni, Francesco Dentali, Andrea Fabbri, Iolanda Enea, Fulvio Pomero, Maria Pia Ruggieri, Andrea di Lenarda.
: Maria Cristina Vedovati, M.D., Chair, Michele Duranti, M.D., Radiologist, Francesco Guercini, M.D., Paolo Groff, M.D., Melina Verso, M.D.
: All study procedures were in accordance with National and International regulations on Ethical standards for clinical research.
: All patients provided informed consent.